Clinically Overt Venous Thromboembolism after Urologic Cancer Surgery: Results from the @RISTOS Study

European Urology

Volumn 51, Issue 1, 2007, Pages 130-136

  Scarpa, Roberto M ^a   Carrieri, Giuseppe ^b   Gussoni, Gualberto ^c   Tubaro, Andrea ^d   Conti, Giario ^e   Pagliarulo, Vincenzo ^f   Mirone, Vincenzo ^g   De Lisa, Antonello ^h   Fiaccavento, Gaspare ⁱ   Cormio, Luigi ^b   Bonizzoni, Erminio ^j   Agnelli, Giancarlo ^k  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF FOGGIA   (Italy)

^c Italfarmaco SpA   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

^e SANT ANNA HOSPITAL   (Italy)

^f UNIVERSITY OF BARI   (Italy)

^g UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^h UNIVERSITY OF CAGLIARI   (Italy)

ⁱ Portogruaro Hospital   (Italy)

^j UNIVERSITY OF MILAN   (Italy)

^k UNIVERSITY OF PERUGIA   (Italy)

more..

Author keywords

Deep vein thrombosis; Prophylaxis; Pulmonary embolism; Urologic cancer surgery; Venous thromboembolism

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; HEPARIN; HEPARINOID; LOW MOLECULAR WEIGHT HEPARIN;

ADULT; AGED; ARTICLE; BLADDER CANCER; BLEEDING; CANCER PATIENT; CANCER SURGERY; CAUSE OF DEATH; COMPARATIVE STUDY; CONTROLLED STUDY; ENDOSCOPIC SURGERY; EQUIPMENT; FEMALE; GENERAL SURGERY; GYNECOLOGIC SURGERY; HOSPITAL CARE; HUMAN; INCIDENCE; LENGTH OF STAY; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; RISK FACTOR; THROMBOSIS PREVENTION; TRANSFUSION; URINARY TRACT CANCER; UROLOGIC SURGERY; VENOUS THROMBOEMBOLISM;

AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; RISK FACTORS; THROMBOEMBOLISM; UROGENITAL NEOPLASMS; VENOUS THROMBOSIS;

EID: 34447554952     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2006.07.014     Document Type: Article

References (17)

1. Gallus A.S. Prevention of post-operative deep leg vein thrombosis in patients with cancer. Thromb Haemost 78 (1997) 126-132
2. Geerts W.H., Heit J.A., Pineo G.F., et al. Prevention of venous thromboembolism. The seventh ACCP Conference on Venous Thromboembolism. Chest 126 (2004) 338S-400S
3. ENOXACAN Study Group. Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: a double-blind randomised multicentre trial with venographic assessment. Br J Surg 84 (1997) 1099-1103
4. Lowe G.D.O., Sandercock P.A.G., and Rosendaal F.R. Prevention of venous thromboembolism after orthopaedic surgery: is fondaparinux an advance?. Lancet 362 (2003) 504-505
5. Brenner D.W., Fogle M.A., and Schellhammer P.F. VTE. J Urol 142 (1989) 1403-1411
6. Kible A.S., and Loughlin K.R. Pathogenesis and prophylaxis of postoperative thromboembolic disease in urological pelvic surgery. J Urol 153 (1995) 1763-1774
7. Koch M.O., and Smith J.A. Low molecular weight heparin and radical prostatectomy: a prospective analysis of safety and side effects. Prostate Cancer Prostatic Dis 1 (1997) 101-104
8. Becker J., Borgstrom S., and Saltzman G.F. Occurrence and course of thrombosis following prostatectomy. A phlebographic investigation. Acta Radiol Diagn 10 (1970) 513-533
9. Sebeseri O., Kummer H., and Zingg E. Controlled prevention of post-operative thrombosis in urological diseases with depot heparin. Eur Urol 1 (1975) 229-230
10. Coe N.D., Collins R.E.C., Klein L.A., et al. Prevention of deep venous thrombosis in urological patients a controlled randomized study of low-dose heparin and external pneumatic compression boots. Surgery 83 (1978) 230-234
11. Leandri P., Rossignol G., Gautier J.R., and Ramon J. Radical retropubic prostatectomy: morbidity and quality of life. Experience with 620 consecutive cases. J Urol 147 (1992) 883-887
12. Agnelli G., Bolis G., Capussotti L., et al. A clinical-outcome based prospective study on venous thromboembolism after cancer surgery: the @RISTOS project. Ann Surg 243 (2006) 89-95
13. Dillioglugil O., Leibman B.D., Leibman N.S., Kattan M.W., Rosas A.L., and Scardino P.T. Risk factors for complications and morbidity after radical retropubic prostatectomy. J Urol 157 (1997) 1760-1767
14. Heinzer H., Hammerer P., Graefen M., and Huland H. Thromboembolic complication rate after radical retropubic prostatectomy impact of routine ultrasonography for the detection of pelvic lymphoceles and hematomas. Eur Urol 33 (1998) 86-90
15. Galvin D.J., Mulvin D., and Quinlan D.M. Thromboprophylaxis for radical prostatectomy: a comparative analysis of present practice between the USA, the UK, and Ireland. Prostate 60 (2004) 338-342
16. Bergqvist D., Agnelli G., Cohen A.T., et al. Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. N Engl J Med 346 (2002) 975-980
17. Sieber P.R., Rommel F.M., Agusta V.E., et al. Is heparin contraindicated in pelvic lymphadenectomy and radical prostatectomy?. J Urol 158 (1997) 869-871